Current Ratio in % of Acrivon Therapeutics, Inc. from Q2 2023 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Acrivon Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2023 to Q3 2025.
Acrivon Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 1.02K %, a 19.5% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Acrivon Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	1.02K	-247	-19.5%	Sep 30, 2025
Q2 2025	1.12K	-206	-15.5%	Jun 30, 2025
Q1 2025	1.24K	-157	-11.3%	Mar 31, 2025
Q4 2024	1.27K	-292	-18.7%	Dec 31, 2024
Q3 2024	1.27K	-677	-34.8%	Sep 30, 2024
Q2 2024	1.32K	-581	-30.5%	Jun 30, 2024
Q1 2024	1.4K			Mar 31, 2024
Q4 2023	1.56K			Dec 31, 2023
Q3 2023	1.94K			Sep 30, 2023
Q2 2023	1.91K			Jun 30, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.